Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 10:2018:2898962.
doi: 10.1155/2018/2898962. eCollection 2018.

Prospective Evaluation of Unprocessed Core Needle Biopsy DNA and RNA Yield from Lung, Liver, and Kidney Tumors: Implications for Cancer Genomics

Affiliations

Prospective Evaluation of Unprocessed Core Needle Biopsy DNA and RNA Yield from Lung, Liver, and Kidney Tumors: Implications for Cancer Genomics

Mikhail T Silk et al. Anal Cell Pathol (Amst). .

Abstract

Context: Targeted needle biopsies are increasingly performed for the genetic characterization of cancer. While the nucleic acid content of core needle biopsies after standard pathology processing (i.e., formalin fixation and paraffin embedding (FFPE)) has been previously reported, little is known about the potential yield for molecular analysis at the time of biopsy sample acquisition.

Objectives: Our objective was to improve the understanding of DNA and RNA yields from commonly used core needle biopsy techniques prior to sample processing.

Methods: We performed 552 ex vivo 18 and 20G core biopsies in the lungs, liver, and kidneys. DNA and RNA were extracted from fresh-frozen core samples and quantified for statistical comparisons based on needle gauge, biopsy site, and tissue type.

Results: Median tumor DNA yields from all 18G and 20G samples were 5880 ng and 2710 ng, respectively. Median tumor RNA yields from all 18G and 20G samples were 1100 ng and 230 ng, respectively. A wide range of DNA and RNA quantities (1060-13,390 ng and 370-6280 ng, respectively) were acquired. Median DNA and RNA yields from 18G needles were significantly greater than those from 20G needles across all organs (p < 0.001).

Conclusions: Core needle biopsy techniques for cancer diagnostics yield a broad range of DNA and RNA for molecular pathology, though quantities are greater than what has been reported for FFPE processed material. Since non-formalin-fixed DNA is advantageous for molecular studies, workflows that optimize core needle biopsy yield for molecular characterization should be explored.

PubMed Disclaimer

Figures

Figure 1
Figure 1
DNA content by tissue type and needle gauge in (a) lung tumors, (b) liver tumors, and (c) kidney tumors (N18 = normal tissue/18 gauge, T18 = tumor tissue/18 gauge, N20 = normal tissue/20 gauge, and T20 = tumor tissues/20 gauge). The dark bar represents median DNA quantity, the surrounding box encompasses the 25–75% interquartile range (IQR), and the brackets reflect 1.5IQR. Diamonds represent statistical outliers.
Figure 2
Figure 2
Logarithmic scale of RNA content by tissue type and needle gauge in (a) lung tumors, (b) liver tumors, and (c) kidney tumors (N18 = normal tissue/18 gauge, T18 = tumor tissue/18 gauge, N20 = normal tissue/20 gauge, T20 = tumor tissues/20 gauge). The dark bar is the median, the box encompasses the 25–75 interquartile range (IQR), the dotted brackets are 1.5IQR, and dots are outliers.

Similar articles

Cited by

References

    1. Chapman P. B., Hauschild A., Robert C., et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. The New England Journal of Medicine. 2011;364(26):2507–2516. doi: 10.1056/NEJMoa1103782. - DOI - PMC - PubMed
    1. Druker B. J., Talpaz M., Resta D. J., et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. The New England Journal of Medicine. 2001;344(14):1031–1037. doi: 10.1056/NEJM200104053441401. - DOI - PubMed
    1. Slamon D. J., Leyland-Jones B., Shak S., et al. Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2. The New England Journal of Medicine. 2001;344(11):783–792. doi: 10.1056/NEJM200103153441101. - DOI - PubMed
    1. Marshall D., Laberge J. M., Firetag B., Miller T., Kerlan R. K. The changing face of percutaneous image-guided biopsy: molecular profiling and genomic analysis in current practice. Journal of Vascular and Interventional Radiology. 2013;24(8):1094–1103. doi: 10.1016/j.jvir.2013.04.027. - DOI - PubMed
    1. Gupta S., Wallace M. J., Cardella J. F., et al. Quality improvement guidelines for percutaneous needle biopsy. Journal of Vascular and Interventional Radiology. 2010;21(7):969–975. doi: 10.1016/j.jvir.2010.01.011. - DOI - PubMed